Impact of recalcification on procoagulant collagen-and-thrombin–activated (COAT) platelet generation in platelet-rich plasma samples with low platelet counts

Optimized PRP recalcification prevents underestimation of procoagulant platelet potential in thrombocytopenic samples. This practical approach addresses a key gap identified by the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee and helps laboratories to ensure reliable platelet function testing in PRP samples from thrombocytopenic patients.

Authors

Institutions

Publication Details

Journal
Research and Practice in Thrombosis and Haemostasis
Published
2026-01-29
DOI
https://doi.org/10.1016/j.rpth.2026.103372
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of recalcification on procoagulant collagen-and-thrombin–activated (COAT) platelet generation in platelet-rich plasma samples with low platelet counts

Lucas Veuthey, Alessandro Aliotta, Kamand Haeri, Manuel Krüsi et al.
Research and Practice in Thrombosis and Haemostasis
Platelet Disorders and Treatments
article

Impact of recalcification on procoagulant collagen-and-thrombin–activated (COAT) platelet generation in platelet-rich plasma samples with low platelet counts

Lucas Veuthey, Alessandro Aliotta, Kamand Haeri, Manuel Krüsi, Lydia Hayenga, Lorenzo Alberio, Debora Bertaggia Calderara
article en

Abstract

Optimized PRP recalcification prevents underestimation of procoagulant platelet potential in thrombocytopenic samples. This practical approach addresses a key gap identified by the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee and helps laboratories to ensure reliable platelet function testing in PRP samples from thrombocytopenic patients.

Research and Practice in Thrombosis and HaemostasisVol. 10(2)
University of Lausanne (CH)
National Science Foundation, Novartis Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Schweizerische Herzstiftung, Novartis Stiftung für Medizinisch-Biologische Forschung
Openalex Percentile: Top 76%
Platelet Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.